These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7462752)

  • 1. [Disorders of lipid metabolism assessed by the changes in the plasma concentrations of apolipoproteins (author's transl)].
    Koga S
    Nihon Naika Gakkai Zasshi; 1980 Oct; 69(10):1239-41. PubMed ID: 7462752
    [No Abstract]   [Full Text] [Related]  

  • 2. [Plasma apolipoprotein E levels in hyperlipidemia (author's transl)].
    Yamada N; Murase T; Akanuma Y; Kosaka K
    Nihon Naika Gakkai Zasshi; 1981 Sep; 70(9):1249-53. PubMed ID: 7320607
    [No Abstract]   [Full Text] [Related]  

  • 3. Apolipoprotein status in type 2 diabetes mellitus and its complications (Review).
    Zhang P; Gao J; Pu C; Zhang Y
    Mol Med Rep; 2017 Dec; 16(6):9279-9286. PubMed ID: 29152661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma apolipoproteins in dyslipoproteinemias. III. LCAT deficiency and other hyperlipidemias].
    Duclos P; Davignon J
    Union Med Can; 1978 Jul; 107(7):637-43. PubMed ID: 208210
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of physical exertion on blood and plasma parameters in healthy subjects and patients with metabolic diseases].
    Mühlfellner G; Mühlfellner O; Neitzert A; Stelbrink U; Zöfel P; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1975; 81():636-9. PubMed ID: 1229570
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperlipidaemia and cardiovascular disease: apolipoprotein measurements and metabolic syndrome as predictors of cardiovascular risk.
    Deans KA; Dominiczak MH
    Curr Opin Lipidol; 2008 Dec; 19(6):624-6. PubMed ID: 18957887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
    Zöller H; Gross W
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):493-4. PubMed ID: 178994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyperlipoproteinaemia and diabetes mellitus (author's transl)].
    Krejsová Z; Bílková H
    Cas Lek Cesk; 1976 Jun; 115(24):721-4. PubMed ID: 954027
    [No Abstract]   [Full Text] [Related]  

  • 9. [Disturbances of lipoprotein and fatty acid metabolism in patients with heavy injuries (author's transl)].
    Wolfram G; Eckart J; Zöllner N
    Klin Wochenschr; 1980 Dec; 58(24):1327-37. PubMed ID: 6782330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clearance and protective factors of HDL-cholesterol (author's transl)].
    Ageta M; Yamasaki S
    Rinsho Byori; 1981 Feb; 29(2):121-30. PubMed ID: 7230529
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma lipids, lipoproteins, and apolipoproteins in Nigerian diabetes mellitus, essential hypertension, and hypertensive-diabetic patients.
    Oyelola OO; Ajayi AA; Babalola RO; Stein EA
    J Natl Med Assoc; 1995 Feb; 87(2):113-8. PubMed ID: 7897682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective study on serum lipids and lipoproteins in the Zulian state (author's transl)].
    Gómez Ocando FA; Lugo Rivas A; Lugo Muñóz A; Montiel Montiel R; Atencio de Gómez B
    Acta Cient Venez; 1977; 28(1):94-8. PubMed ID: 865782
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship of sFas with metabolic risk factors and their clusters.
    Tamakoshi A; Suzuki K; Lin Y; Ito Y; Yagyu K; Kikuchi S; Watanabe Y; Inaba Y; Tajima K; Nakachi K;
    Eur J Clin Invest; 2010 Jun; 40(6):527-33. PubMed ID: 20584172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on clinical application of serum lipoprotein fractionation (author's transl)].
    Okishio T; Taku K
    Rinsho Byori; 1975 Jan; 23(1):20-4. PubMed ID: 1168269
    [No Abstract]   [Full Text] [Related]  

  • 15. [Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].
    Zöller H
    Klin Wochenschr; 1978 Aug; 56(16):789-95. PubMed ID: 357836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis of lipid metabolism disorders].
    Schimke E
    Z Arztl Fortbild (Jena); 1990; 84(21):1089-91. PubMed ID: 2281693
    [No Abstract]   [Full Text] [Related]  

  • 17. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in non-insulin-dependent diabetes mellitus.
    Kissebah AH; Alfarsi S; Evans DJ; Adams PW
    Diabetes; 1982 Mar; 31(3):217-25. PubMed ID: 7152129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOLIPOPROTEINS AND THEIR ASSOCIATION WITH CARDIOMETABOLIC RISK BIOMARKERS IN ADOLESCENTS.
    Neyla de Lima Albuquerque M; da Silva Diniz A; Kruze Grande de Arruda I
    Nutr Hosp; 2015 Dec; 32(6):2674-83. PubMed ID: 26667720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of sucrose and invert sugar on the levels of plasma lipids, plasma ApoA concentrations and chemical composition of high density lipoprotein subfractions in healthy young males (author's transl)].
    Iwasaki Y; Aono M
    Nihon Naika Gakkai Zasshi; 1981 Aug; 70(8):1105-11. PubMed ID: 7299231
    [No Abstract]   [Full Text] [Related]  

  • 20. [Differentiation of VLDL subfraction in the diagnosis of type III hyperlipoproteinaemias (author's transl)].
    Vogelberg KH
    J Clin Chem Clin Biochem; 1977 Jul; 15(7):389-92. PubMed ID: 197199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.